Biography

• Dr.Teng has received his Ph.D and M.D degrees in gynaecology and obstetrics from the Shanghai Jiao Tong University of Medicine. He is now the head, chief physician, professor and doctoral supervisor of the Department of Obstetrics and Gynecology of the Sixth People's Hospital Affiliated to Shanghai Jiao Tong University of Medicine. He holds the post of the director of Shanghai Consultation and Rescue Center for Critically Pregnant Women and the director of Reproductive Medicine Center in Shanghai Sixth People's Hospital，and the deputy director of Department of Obstetrics and Gynecology of Shanghai Jiao Tong University School of Medicine. He has been long dedicated to the researches on the pathogenesis and drug resistance mechanisms of gynecological cancers (cervical，endometrial and ovarian cancer)，presiding over 4 National Natural Science Foundation projects and 10 + municipal projects in Shanghai. Related research works were published in journals such as Oncogene, Cell Death and Disease, Cancer letters, Cancer, Ebiomedcine, etc., with a cumulative impact factor of more than 170 points. He has won the honorary titles such as Shanghai Leading Talent and Shanghai Outstanding Specialist，as well as third prizes of Shanghai Science and Technology Award & Shanghai Medical Science and Technology Award.

Publications

1. Yang B, Chen J, Li X, Zhang X, Hu L, Jiang S, Zhang Z, Teng Y. TNPO1-mediated nuclear import of ARID1B promotes tumor growth in ARID1A-deficient gynecologic cancer. Cancer letters. 2021;515:14-27.

2. Dai M, Yang B, Chen J, Liu F, Zhou Y, Zhou Y, Xu Q, Jiang S, Zhao S, Li X, Zhou X, Yang Q, Li J, Wang Y, Zhang Z, Teng Y. Nuclear-translocation of ACLY induced by obesity-related factors enhances pyrimidine metabolism through regulating histone acetylation in endometrial cancer. Cancer letters. 2021;513:36-49.

3. Zhou Y, Liu F, Xu Q, Yang B, Li X, Jiang S, Hu L, Zhang X, Zhu L, Li Q, Zhu X, Shao H, Dai M, Shen Y, Ni B, Wang S, Zhang Z, Teng Y. Inhibiting Importin 4-mediated nuclear import of CEBPD enhances chemosensitivity by repression of PRKDC-driven DNA damage repair in cervical cancer. Oncogene. 2020.

4. Xu Q, Ge Q, Zhou Y, Yang B, Yang Q, Jiang S, Jiang R, Ai Z, Zhang Z, Teng Y. MELK promotes Endometrial carcinoma progression via activating mTOR signaling pathway. EBioMedicine. 2020;51:102609.

5. Liu F, Dai M, Xu Q, Zhu X, Zhou Y, Jiang S, Wang Y, Ai Z, Ma L, Zhang Y, Hu L, Yang Q, Li J, Zhao S, Zhang Z, Teng Y: SRSF10-mediated IL1RAP alternative splicing regulates cervical cancer oncogenesis via mIL1RAP-NF-kappaB-CD47 axis. Oncogene 2018, 37:2394-409.

6. Ge Q, Liu S, Ai Z, Tao M, Ma L, Wen S, Dai M, Liu F, Liu H, Jiang R, Xue Z, Jiang Y, Sun XH, Hu Y, Zhao Y, Chen X, Tao Y, Zhu X, Ding W, Yang B, Liu D, Zhang X, Teng Y: RelB/NF-kappaB links cell cycle transition and apoptosis to endometrioid adenocarcinoma tumorigenesis. Cell death & disease 2016, 7:e2402.